What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Disease
His main research concerns Internal medicine, Nonalcoholic fatty liver disease, Fatty liver, Gastroenterology and Endocrinology.
His work on Steatohepatitis, Steatosis and Liver disease as part of his general Internal medicine study is frequently connected to Vitamin E, thereby bridging the divide between different branches of science.
His Nonalcoholic fatty liver disease research is multidisciplinary, relying on both Grading, Overweight, Chronic liver disease, Alanine transaminase and Disease management.
The various areas that he examines in his Fatty liver study include Placebo, Magnetic resonance imaging, Computed tomography and Hepatitis.
His Gastroenterology study combines topics in areas such as Fibrosis, Liver biopsy, Disease and Insulin resistance.
His Endocrinology study deals with Family aggregation intersecting with TM6SF2.
His most cited work include:
- The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association (2522 citations)
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. (2005 citations)
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis (1964 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Nonalcoholic fatty liver disease, Gastroenterology, Fatty liver and Endocrinology.
His studies examine the connections between Internal medicine and genetics, as well as such issues in Diabetes mellitus, with regards to Cross-sectional study.
His biological study spans a wide range of topics, including Steatosis, Obesity, Liver biopsy, Liver disease and Steatohepatitis.
His work in Liver disease tackles topics such as Epidemiology which are related to areas like Childhood obesity.
His Gastroenterology research includes elements of Nonalcoholic steatohepatitis, Placebo, Biopsy and Metabolic syndrome.
Joel E. Lavine has included themes like Chronic liver disease, Alanine transaminase, Odds ratio and In vivo magnetic resonance spectroscopy in his Fatty liver study.
He most often published in these fields:
- Internal medicine (73.08%)
- Nonalcoholic fatty liver disease (58.79%)
- Gastroenterology (56.04%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (73.08%)
- Nonalcoholic fatty liver disease (58.79%)
- Gastroenterology (56.04%)
In recent papers he was focusing on the following fields of study:
Joel E. Lavine mainly focuses on Internal medicine, Nonalcoholic fatty liver disease, Gastroenterology, Fibrosis and Steatosis.
His study looks at the relationship between Internal medicine and topics such as Diabetes mellitus, which overlap with Testosterone.
Joel E. Lavine studied Nonalcoholic fatty liver disease and Cirrhosis that intersect with Liver disease, Liver biopsy and Hepatology.
His Gastroenterology research is multidisciplinary, incorporating elements of Nonalcoholic steatohepatitis, Fatty liver, Placebo, Insulin resistance and Stage.
The Hepatic fibrosis research he does as part of his general Fibrosis study is frequently linked to other disciplines of science, such as Low testosterone, therefore creating a link between diverse domains of science.
His research investigates the connection with Steatosis and areas like Proton density fat fraction which intersect with concerns in Nuclear medicine and Radiology.
Between 2017 and 2021, his most popular works were:
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. (2005 citations)
- Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis (172 citations)
- Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis (154 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
His primary areas of study are Nonalcoholic fatty liver disease, Internal medicine, Fibrosis, Gastroenterology and Cirrhosis.
His research integrates issues of Alternative medicine, Guideline, Family medicine and Mass screening in his study of Nonalcoholic fatty liver disease.
His works in Steatohepatitis, Hepatology, Body mass index, Steatosis and Prospective cohort study are all subjects of inquiry into Internal medicine.
His work on Hepatic fibrosis is typically connected to Hepatocyte as part of general Fibrosis study, connecting several disciplines of science.
His Gastroenterology research is multidisciplinary, relying on both Stage and Biopsy.
In Cirrhosis, he works on issues like Liver disease, which are connected to Transient elastography.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
